Splenectomy and acute splenic sequestration crises in sickle cell disease

Area of Science:

• Hematology
• Pediatric Medicine
• Genetics

Background:

• Acute splenic sequestration crises (ASSC) are a life-threatening complication of sickle cell disease (SCD).
• ASSC involves significant blood volume loss, leading to severe anemia and potential circulatory collapse.
• SCD affects individuals of various ages, with ASSC being a critical concern.

Purpose of the Study:

• To describe the clinical features of ASSC in a cohort of patients with SCD.
• To evaluate the management and outcomes of ASSC, focusing on the role of splenectomy.
• To provide insights into the long-term effects of ASSC and its treatment.

Main Methods:

• Retrospective review of 19 patients diagnosed with ASSC over a 5-year period.
• Analysis of patient demographics, SCD genotype (homozygous SCD and sickle thalassemia), and clinical presentations.
• Evaluation of treatment strategies, including splenectomy for major sequestration episodes and conservative management for minor episodes.

Main Results:

• Nineteen patients (14 males, 5 females) aged 4-32 years were treated for ASSC.
• Two patients presented with severe anemia and circulatory collapse; one experienced residual limb weakness and vision impairment.
• Nine patients underwent splenectomy, while 10 were managed for recurrent minor sequestration episodes.

Conclusions:

• ASSC is a severe complication of SCD requiring prompt recognition and management.
• Splenectomy may be indicated for major ASSC episodes, while recurrent minor episodes require careful monitoring.
• Understanding the clinical spectrum and treatment outcomes is crucial for improving patient care in SCD.